120 related articles for article (PubMed ID: 26479422)
1. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
Mehta N; Sarkar M; Dodge JL; Fidelman N; Roberts JP; Yao FY
Liver Transpl; 2016 Feb; 22(2):178-87. PubMed ID: 26479422
[TBL] [Abstract][Full Text] [Related]
2. A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
Mehta N; Dodge JL; Roberts JP; Yao FY
J Hepatol; 2021 Apr; 74(4):829-837. PubMed ID: 33188904
[TBL] [Abstract][Full Text] [Related]
3. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.
Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
Am J Transplant; 2019 Aug; 19(8):2210-2218. PubMed ID: 30861298
[TBL] [Abstract][Full Text] [Related]
4. National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time.
Mehta N; Dodge JL; Grab JD; Yao FY
Hepatology; 2020 Mar; 71(3):943-954. PubMed ID: 31344273
[TBL] [Abstract][Full Text] [Related]
5. Significant Reduction in Posttransplant Hepatocellular Carcinoma Recurrence in the Post 6-Mo Waiting Policy Era.
Mahmud N; Yagan L; Hoteit MA; Reddy KR; Abt PL; Abu-Gazala S
Transplantation; 2024 May; 108(5):1172-1178. PubMed ID: 37953481
[TBL] [Abstract][Full Text] [Related]
6. Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy Change.
Saberi B; Gurakar A; Tamim H; Schneider CV; Sims OT; Bonder A; Fricker Z; Alqahtani SA
JAMA Netw Open; 2023 Nov; 6(11):e2341096. PubMed ID: 37917059
[TBL] [Abstract][Full Text] [Related]
7. Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis.
Sogawa H; Shrager B; Jibara G; Tabrizian P; Roayaie S; Schwartz M
HPB (Oxford); 2013 Feb; 15(2):134-41. PubMed ID: 23036070
[TBL] [Abstract][Full Text] [Related]
8. Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.
Sarkar M; Dodge JL; Roberts JP; Terrault N; Yao F; Mehta N
Ann Hepatol; 2016; 15(4):545-9. PubMed ID: 27236153
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm.
Samoylova ML; Dodge JL; Mehta N; Yao FY; Roberts JP
Clin Transplant; 2015 Jan; 29(1):52-9. PubMed ID: 25366656
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study.
Martel-Laferrière V; Michel A; Schaefer S; Bindal S; Bichoupan K; Branch AD; Huprikar S; Schiano TD; Perumalswami PV
Transpl Infect Dis; 2015 Aug; 17(4):527-35. PubMed ID: 25929731
[TBL] [Abstract][Full Text] [Related]
11. The number of hepatocellular carcinoma foci as predictor of poor response to tumor-directed therapies in patients awaiting liver transplantation: a prospective cohort study.
Aydin Y; Koksal AR; Thevenot P; Nunez K; Elgamal M; Koksal UI; Sandow T; Moehlen M; Regenstein F; Tahan V; Cohen A
Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1224-1229. PubMed ID: 37577793
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation and hepatocellular carcinoma 2023: a narrative review of management and outcomes.
Tabrizian P; Holzner ML; Zaret D; Meyerovich G; Fagenson A; Schiano T
Ann Palliat Med; 2024 Jan; 13(1):126-140. PubMed ID: 38124475
[TBL] [Abstract][Full Text] [Related]
13. Who should undergo liver transplantation for hepatocellular carcinoma? Ablate, wait … and see!
Naugler WE; Schlansky B; Orloff SL
Hepat Oncol; 2014 Apr; 1(2):165-168. PubMed ID: 30190949
[No Abstract] [Full Text] [Related]
14. Letter to the editor in response to: A case of pediatric alcohol-associated hepatitis evaluated for liver transplant listing.
Hildreth A; Schwimmer JB
JPGN Rep; 2024 May; 5(2):235. PubMed ID: 38756136
[No Abstract] [Full Text] [Related]
15. Managing a Prospective Liver Transplant Recipient on the Waiting List.
Sharma M; Alla M; Kulkarni A; Nagaraja Rao P; Nageshwar Reddy D
J Clin Exp Hepatol; 2024; 14(1):101203. PubMed ID: 38076359
[TBL] [Abstract][Full Text] [Related]
16. Optimal treatment for small HCC (<3 cm): Resection, liver transplantation, or locoregional therapy?
Wu X; Lokken RP; Mehta N
JHEP Rep; 2023 Aug; 5(8):100781. PubMed ID: 37456674
[TBL] [Abstract][Full Text] [Related]
17. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Singal AG; Llovet JM; Yarchoan M; Mehta N; Heimbach JK; Dawson LA; Jou JH; Kulik LM; Agopian VG; Marrero JA; Mendiratta-Lala M; Brown DB; Rilling WS; Goyal L; Wei AC; Taddei TH
Hepatology; 2023 Dec; 78(6):1922-1965. PubMed ID: 37199193
[No Abstract] [Full Text] [Related]
18. Long-term outcomes of ablation, liver resection, and liver transplant as first-line treatment for solitary HCC of 3 cm or less using an intention-to-treat analysis: A retrospective cohort study.
Ivanics T; Rajendran L; Abreu PA; Claasen MPAW; Shwaartz C; Patel MS; Choi WJ; Doyle A; Muaddi H; McGilvray ID; Selzner M; Beecroft R; Kachura J; Bhat M; Selzner N; Ghanekar A; Cattral M; Sayed B; Reichman T; Lilly L; Sapisochin G
Ann Med Surg (Lond); 2022 May; 77():103645. PubMed ID: 35637985
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant treatment strategies for hepatocellular carcinoma.
Xu L; Chen L; Zhang W
World J Gastrointest Surg; 2021 Dec; 13(12):1550-1566. PubMed ID: 35070063
[TBL] [Abstract][Full Text] [Related]
20. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation.
Ogawa K; Takada Y
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
